1-2 of 2
Ronald Hoffman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

LKB1/STK11 Is a Tumor Suppressor in the Progression of Myeloproliferative Neoplasms

Christian Marinaccio, Praveen Suraneni, Hamza Celik, Andrew Volk, Qiang Jeremy Wen, Te Ling, Marinka Bulic, Terra Lasho, Richard P. Koche, Christopher A. Famulare, Noushin Farnoud, Brady Stein, Michael Schieber, Sandeep Gurbuxani, David E. Root, Scott T. Younger, Ronald Hoffman, Naseema Gangat, Panagiotis Ntziachristos, Navdeep S. Chandel, Ross L. Levine, Raajit K. Rampal, Grant A. Challen, Ayalew Tefferi, John D. Crispino
Journal: Cancer Discovery
Cancer Discov (2021) 11 (6): 1398–1410.
https://doi.org/10.1158/2159-8290.CD-20-1353
Published: 01 June 2021
View articletitled, LKB1/STK11 Is a Tumor Suppressor in the Progression of Myeloproliferative Neoplasms
Open the PDF for LKB1/STK11 Is a Tumor Suppressor in the Progression of Myeloproliferative Neoplasms in another window
Includes: Supplementary data
Journal Articles

Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T-cell Immunity Directed against Mutated Calreticulin in Myeloproliferative Neoplasms

Cansu Cimen Bozkus, Vladimir Roudko, John P. Finnigan, John Mascarenhas, Ronald Hoffman, Camelia Iancu-Rubin, Nina Bhardwaj
Journal: Cancer Discovery
Cancer Discov (2019) 9 (9): 1192–1207.
https://doi.org/10.1158/2159-8290.CD-18-1356
Published: 03 September 2019
View articletitled, Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T-cell Immunity Directed against Mutated Calreticulin in Myeloproliferative Neoplasms
Open the PDF for Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T-cell Immunity Directed against Mutated Calreticulin in Myeloproliferative Neoplasms in another window
Includes: Supplementary data